Concepedia

Régine Buffels

RB

Statistics

Publications

6

Citations

256

H-Index

6

Active since

2002

Affiliations

Roche (Switzerland)(Current)

Inserm

University Hospital of Basel

Vall d'Hebron Hospital Universitari

University of California, San Francisco

Régine Buffels is an author at Roche (Switzerland) specializing in hematology, pharmacotherapy, and cancer research.

Top concepts

Publications per year

2002–2023

6

Publications

6

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis

Benjamin Turner, Bruce Cree, Ludwig Kappos et al. · Journal of Neurology · 2019 · 78 citations · Full text

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a

Eva Havrdová, Douglas L. Arnold, Amit Bar‐Or et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2018 · 56 citations · Full text

Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I–II study

Régine Buffels, E. Gacos, Chryssa Vadikolia et al. · British Journal of Haematology · 2002 · 43 citations

, , +16

Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from the phase 3b CASTING single‐arm, open‐label trial

Patrick Vermersch, Celia Oreja‐Guevara, Bart Van Wijmeersch et al. · European Journal of Neurology · 2021 · 28 citations · Full text

Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis

H-P Hartung, Thomas Berger, R. Bermel et al. · Multiple Sclerosis and Related Disorders · 2020 · 26 citations · Full text

1–5 of 6